{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,27]],"date-time":"2025-10-27T04:50:27Z","timestamp":1761540627819},"reference-count":67,"publisher":"Elsevier BV","issue":"16","license":[{"start":{"date-parts":[[2005,4,1]],"date-time":"2005-04-01T00:00:00Z","timestamp":1112313600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Medicina Cl\u00ednica"],"published-print":{"date-parts":[[2005,4]]},"DOI":"10.1157\/13074395","type":"journal-article","created":{"date-parts":[[2005,5,3]],"date-time":"2005-05-03T10:04:36Z","timestamp":1115114676000},"page":"630-633","source":"Crossref","is-referenced-by-count":3,"title":["Manifestaciones neurol\u00f3gicas en el s\u00edndrome antifosfolip\u00eddico"],"prefix":"10.1016","volume":"124","author":[{"given":"Luisa","family":"Su\u00e1rez \u00c1lvarez","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Graham R.V.","family":"Hughes","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Munther A.","family":"Khamashta","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1157\/13074395_bib1","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1136\/pmj.79.928.81","article-title":"Migraine, memory loss, and \u00abmultiple sclerosis\u00bb. Neurological features of the antiphospholipid (Hughes\u2019) syndrome","volume":"79","author":"Hughes","year":"2003","journal-title":"Postgrad Med J"},{"key":"10.1157\/13074395_bib2","doi-asserted-by":"crossref","first-page":"1088","DOI":"10.1136\/bmj.287.6399.1088","article-title":"Thrombosis, abortion, cerebral disease and the lupus anticoagulant","volume":"287","author":"Hughes","year":"1983","journal-title":"Br Med J"},{"key":"10.1157\/13074395_bib3","doi-asserted-by":"crossref","first-page":"1309","DOI":"10.1002\/1529-0131(199907)42:7<1309::AID-ANR1>3.0.CO;2-F","article-title":"International consensus statement on preliminary classification criteria for definite antiphospholipid syndrome: report of an international workshop","volume":"42","author":"Wilson","year":"1999","journal-title":"Arthritis Rheum"},{"key":"10.1157\/13074395_bib4","doi-asserted-by":"crossref","first-page":"200","DOI":"10.1093\/rheumatology\/keg080","article-title":"Central nervous system involvement in the antiphospholipid (Hughes) syndrome","volume":"42","author":"Sanna","year":"2003","journal-title":"Rheumatology"},{"key":"10.1157\/13074395_bib5","first-page":"478","article-title":"Anticuerpos anfifosfol\u00edpido","volume":"183","author":"Monereo","year":"1988","journal-title":"Rev Clin Esp"},{"key":"10.1157\/13074395_bib6","doi-asserted-by":"crossref","first-page":"392","DOI":"10.1191\/096120301678646119","article-title":"Sticky blood and headache","volume":"10","author":"Cuadrado","year":"2001","journal-title":"Lupus"},{"key":"10.1157\/13074395_bib7","doi-asserted-by":"crossref","first-page":"1019","DOI":"10.1002\/art.10187","article-title":"Anthiphospholipid syndrome: clinical and immunologic manifestations and patterns of disease expression in a cohort of 1,000 patients","volume":"46","author":"Cervera","year":"2002","journal-title":"Arthritis Rheum"},{"key":"10.1157\/13074395_bib8","doi-asserted-by":"crossref","first-page":"877","DOI":"10.1191\/0961203303lu496oa","article-title":"APS and the brain","volume":"12","author":"Sastre-Garriga","year":"2003","journal-title":"Lupus"},{"key":"10.1157\/13074395_bib9","doi-asserted-by":"crossref","first-page":"1433","DOI":"10.1212\/WNL.50.5.1433","article-title":"Role of anticardiolipin antibodies in young persons with migraine and transient focal neurological events","volume":"50","author":"Tietjen","year":"1998","journal-title":"Neurology"},{"key":"10.1157\/13074395_bib10","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1046\/j.1468-2982.1992.1202069.x","article-title":"Migraine and antiphospholipid antibodies","volume":"12","author":"Tietjen","year":"1992","journal-title":"Cephalalgia"},{"key":"10.1157\/13074395_bib11","doi-asserted-by":"crossref","first-page":"190","DOI":"10.1046\/j.1468-2982.2000.00041.x","article-title":"Migraine and stroke in young women","volume":"20","author":"Tzourio","year":"2000","journal-title":"Cephalalgia"},{"key":"10.1157\/13074395_bib12","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1046\/j.1468-2982.1991.1102101.x","article-title":"Anticardiolipin antibodies in cluster headache","volume":"11","author":"Hering","year":"1991","journal-title":"Cephalalgia"},{"key":"10.1157\/13074395_bib13","first-page":"P177","article-title":"Prevalence of headache and relationship with the presence of antiphospholipid antibodies in patients with systemic lupus erythematosus","volume":"15","author":"Sanna","year":"2000","journal-title":"J Autoimmun"},{"key":"10.1157\/13074395_bib14","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1093\/qjmed\/93.5.317","article-title":"Migraine and stroke in young women","volume":"93","author":"Cuadrado","year":"2000","journal-title":"Q J Med"},{"key":"10.1157\/13074395_bib15","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1093\/qjmed\/94.2.114","article-title":"Migraine in Hughes syndrome \u2013 heparin as a therapeutic trial?","volume":"94","author":"Cuadrado","year":"2001","journal-title":"Q J Med"},{"key":"10.1157\/13074395_bib16","doi-asserted-by":"crossref","first-page":"778","DOI":"10.1177\/096120330101001103","article-title":"Headache and memory loss: rapid response to heparin in the antiphospholipid syndrome","volume":"10","author":"Hughes","year":"2001","journal-title":"Lupus"},{"key":"10.1157\/13074395_bib17","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1159\/000017211","article-title":"Dementia and antiphospholipid antibodies","volume":"11","author":"Mosek","year":"2000","journal-title":"Dement Geriatr Cogn Disord"},{"key":"10.1157\/13074395_bib18","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1076\/jcen.21.2.251.931","article-title":"Neuropsychological deficits associated with antiphospholipid antibodies","volume":"21","author":"Jacobson","year":"1999","journal-title":"J Clin Exp Neuropsychol"},{"key":"10.1157\/13074395_bib19","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1017\/S1355617797003779","article-title":"The relationship of antiphospholipid antibodies to cognitive function in patients with systemic lupus erythematosus","volume":"3","author":"Denburg","year":"1997","journal-title":"J Int Neuropsychol Soc"},{"key":"10.1157\/13074395_bib20","doi-asserted-by":"crossref","first-page":"728","DOI":"10.1002\/1529-0131(199904)42:4<728::AID-ANR16>3.0.CO;2-O","article-title":"A prospective analysis of cognitive function and anticardiolipin antibodies in systemic lupus erythematosus","volume":"42","author":"Hanly","year":"1999","journal-title":"Arthritis Rheum"},{"key":"10.1157\/13074395_bib21","doi-asserted-by":"crossref","first-page":"735","DOI":"10.1002\/1529-0131(199904)42:4<735::AID-ANR17>3.0.CO;2-L","article-title":"A longitudinal study of anticardiolipin antibody levels and cognitive functioning in systemic lupus erythematosus","volume":"42","author":"Menon","year":"1999","journal-title":"Arthritis Rheum"},{"key":"10.1157\/13074395_bib22","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1111\/j.1600-0404.1989.tb03721.x","article-title":"Lupus anticoagulant and the late onset seizures","volume":"79","author":"Inzelberg","year":"1989","journal-title":"Acta neurol Scand"},{"key":"10.1157\/13074395_bib23","doi-asserted-by":"crossref","first-page":"517","DOI":"10.1212\/01.WNL.0000106821.83436.59","article-title":"Antiphospholipid and glutamic acid decarboxylase antibodies in patients with focal epilepsy","volume":"62","author":"Sokol","year":"2004","journal-title":"Neurology"},{"key":"10.1157\/13074395_bib24","doi-asserted-by":"crossref","first-page":"568","DOI":"10.1002\/art.1780370418","article-title":"Association between antiphospholipid antibodies and epilepsy in patients with systemic lupus erythematosus","volume":"37","author":"Herranz","year":"1994","journal-title":"Arthritis Rheum"},{"key":"10.1157\/13074395_bib25","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1016\/S0002-9343(97)90046-2","article-title":"Prevalence and signification of antinuclear and anticardiolipin antibodies in patients with epilepsy","volume":"103","author":"Verrot","year":"1997","journal-title":"Am J Med"},{"key":"10.1157\/13074395_bib26","doi-asserted-by":"crossref","first-page":"712","DOI":"10.1016\/S0002-9343(00)00617-3","article-title":"Antiphospholipid and antinuclear antibodies in patients with epilepsy or new-onset seizure disorders","volume":"109","author":"Peltola","year":"2000","journal-title":"Am J Med"},{"key":"10.1157\/13074395_bib27","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1191\/096120398678919624","article-title":"Outcome of patients with anticardiolipin antibodies: a 10-year follow-up of 52 patients","volume":"7","author":"Shah","year":"1998","journal-title":"Lupus"},{"key":"10.1157\/13074395_bib28","doi-asserted-by":"crossref","first-page":"2101","DOI":"10.1001\/archinte.157.18.2101","article-title":"A retrospective review of 61 patients with antiphospholipid syndrome","volume":"157","author":"Knic-Barrie","year":"1997","journal-title":"Arch Intern Med"},{"key":"10.1157\/13074395_bib29","first-page":"147","article-title":"Anticuerpos antifosfol\u00edpido e infarto cerebral isqu\u00e9mico en un ni\u00f1o de 6 a\u00f1os","volume":"38","author":"Forastiero","year":"1993","journal-title":"Sangre (Barc)"},{"key":"10.1157\/13074395_bib30","doi-asserted-by":"crossref","first-page":"172","DOI":"10.1212\/WNL.62.2.172","article-title":"Back to school on APS. Rethinking the risk of recurrent stroke in children","volume":"62","author":"Fullerton","year":"2004","journal-title":"Neurology"},{"key":"10.1157\/13074395_bib31","doi-asserted-by":"crossref","first-page":"2069","DOI":"10.1212\/WNL.43.10.2069","article-title":"Anticardiolipine antibodies are an independent risk factor for first ischemic stroke","volume":"43","year":"1993","journal-title":"Neurology"},{"key":"10.1157\/13074395_bib32","doi-asserted-by":"crossref","first-page":"1190","DOI":"10.1212\/WNL.40.8.1190","article-title":"Antiphospholipid antibodies and cerebral ischemia in young people","volume":"40","author":"Brey","year":"1990","journal-title":"Neurology"},{"key":"10.1157\/13074395_bib33","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1016\/0002-9343(89)90335-5","article-title":"Cerebrovascular disease and antiphospholipid antibodies in systemic lupus erythematosus, lupus-like disease and the primary antiphospholipid syndrome","volume":"86","author":"Asherson","year":"1989","journal-title":"Am J Med"},{"key":"10.1157\/13074395_bib34","doi-asserted-by":"crossref","first-page":"1181","DOI":"10.1212\/WNL.40.8.1181","article-title":"Cerebrovascular and neurological disease associated with antiphospholipid antibodies: 48 cases","volume":"40","author":"Levine","year":"1990","journal-title":"Neurology"},{"key":"10.1157\/13074395_bib35","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1016\/S0733-8619(18)30237-8","article-title":"The role of antiphospholipid antibodies and stroke","volume":"10","author":"Coull","year":"1992","journal-title":"Neurol Clin"},{"key":"10.1157\/13074395_bib36","first-page":"188","article-title":"Antiphospholipid antibody associated stroke: prospective assessment of recurrent event risk","volume":"24","author":"Levine","year":"1993","journal-title":"Stroke"},{"key":"10.1157\/13074395_bib37","doi-asserted-by":"crossref","first-page":"1660","DOI":"10.1161\/01.STR.28.9.1660","article-title":"IgG anticardiolipin antibody titer > 40 GPL and the risk of subsequent thrombo-occlusive events and death","volume":"28","author":"Levine","year":"1997","journal-title":"Stroke"},{"key":"10.1157\/13074395_bib38","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1097\/00005792-198911000-00003","article-title":"Antiphospholipid antibodies and the antiphospholipid syndrome in systemic lupus erythematosus: a prospective analysis of 500 consecutive patients","volume":"68","author":"Alarc\u00f3n-Segovia","year":"1989","journal-title":"Medicine (Baltimore)"},{"key":"10.1157\/13074395_bib39","first-page":"551","article-title":"Endothelial cells as target for antiphospholipid antibodies","volume":"40","author":"Del Papa","year":"1997","journal-title":"Arthritis Rheum"},{"key":"10.1157\/13074395_bib40","doi-asserted-by":"crossref","first-page":"212","DOI":"10.1111\/j.1600-0897.1997.tb00301.x","article-title":"Endothelial cells as target for antiphospholipid antibodies: role of antibeta-2-glycoprotein 1 antibodies","volume":"38","author":"Del Papa","year":"1997","journal-title":"Am J Reprod Immunol"},{"key":"10.1157\/13074395_bib41","doi-asserted-by":"crossref","first-page":"1541","DOI":"10.1016\/0140-6736(90)91373-I","article-title":"Association of antibodies against phospholipids with heart valve disease in systemic lupus erythematosus","volume":"335","author":"Khamashta","year":"1990","journal-title":"Lancet"},{"key":"10.1157\/13074395_bib42","doi-asserted-by":"crossref","first-page":"993","DOI":"10.1056\/NEJM199504133321504","article-title":"The management of thrombosis in the antiphospholipid-antibody syndrome","volume":"332","author":"Khamashta","year":"1995","journal-title":"N Engl J Med"},{"key":"10.1157\/13074395_bib43","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1212\/01.WNL.0000072324.59029.92","article-title":"Low dose aspirin after ischemic stroke associated with antiphospholipid syndrome","volume":"61","author":"Derksen","year":"2003","journal-title":"Neurology"},{"key":"10.1157\/13074395_bib44","doi-asserted-by":"crossref","first-page":"1444","DOI":"10.1056\/NEJMoa011258","article-title":"A comparison of warfarin and aspirin for the prevention of recurrent ischemic stroke","volume":"345","author":"Mohr","year":"2001","journal-title":"N Engl J Med"},{"key":"10.1157\/13074395_bib45","doi-asserted-by":"crossref","first-page":"576","DOI":"10.1001\/jama.291.5.576","article-title":"Antiphospholipid antibodies and subsequent thromboocclusive events in patients with ischemic stroke","volume":"291","author":"Levine","year":"2004","journal-title":"JAMA"},{"key":"10.1157\/13074395_bib46","doi-asserted-by":"crossref","first-page":"2701","DOI":"10.1001\/jama.291.22.2701-b","article-title":"Letter in reply to \u00abantiphospholipid antibodies and subsequent thrombo-occlusive events in patients with ischemic stroke\u00bb","volume":"291","author":"Ruiz-Irastorza","year":"2004","journal-title":"JAMA"},{"key":"10.1157\/13074395_bib47","doi-asserted-by":"crossref","first-page":"1724","DOI":"10.1161\/01.STR.27.10.1724","article-title":"Coagulations studies, factor V Leiden, and anticardiolipin antibodies in 40 cases of cerebral venous sinus thrombosis","volume":"27","author":"Descheins","year":"1996","journal-title":"Stroke"},{"key":"10.1157\/13074395_bib48","first-page":"2363","article-title":"Cerebral venous thrombosis and anticardiolipin antibodies","volume":"28","author":"Carhuapoma","year":"1997","journal-title":"Neurology"},{"key":"10.1157\/13074395_bib49","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1136\/ard.59.2.120","article-title":"Transverse myelopathy in systemic lupus erythematosus: an analysis of 14 cases and review of the literature","volume":"59","author":"Kovacs","year":"2000","journal-title":"Ann Rheum Dis"},{"key":"10.1157\/13074395_bib50","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1212\/01.WNL.0000101715.32569.1A","article-title":"Recurrent transverse myelitis associates with anti-Ro (SSA) autoantibodies","volume":"62","author":"Hummers","year":"2004","journal-title":"Neurology"},{"key":"10.1157\/13074395_bib51","first-page":"280","article-title":"Transverse myelitis as the first manifestation of systemic lupus erythematosus or lupus-like disease: good functional outcome and relevance of antiphospholipid antibodies","volume":"31","author":"D\u2019Cruz","year":"2004","journal-title":"J Rheumatol"},{"key":"10.1157\/13074395_bib52","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1097\/00005792-200001000-00006","article-title":"Can neurologic manifestation of Hughes (antiphospholipid) syndrome be distinguished from multiple sclerosis? Analysis of 27 patients and review of the literature","volume":"79","author":"Cuadrado","year":"2000","journal-title":"Medicine (Baltimore)"},{"key":"10.1157\/13074395_bib53","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1191\/096120399678847461","article-title":"Antiphospholipid antibodies in patients with multiple sclerosis and MS-like illnesses: MS or APS?","volume":"8","author":"Ijdo","year":"1999","journal-title":"Lupus"},{"key":"10.1157\/13074395_bib54","doi-asserted-by":"crossref","first-page":"629","DOI":"10.1002\/ana.410440408","article-title":"A subgroup of multiple tions: do they represent a new nosological entity?","volume":"44","author":"Karussis","year":"1998","journal-title":"Ann Neurol"},{"key":"10.1157\/13074395_bib55","first-page":"377","article-title":"Antiphospholipid antibodies and chorea","volume":"15","author":"Asherson","year":"1988","journal-title":"J Rheumatol"},{"key":"10.1157\/13074395_bib56","doi-asserted-by":"crossref","first-page":"308","DOI":"10.1542\/peds.61.2.308","article-title":"Chorea associated with systemic lupus erythematosus: report of two cases and review of the literature","volume":"61","author":"Herd","year":"1978","journal-title":"Pediatrics"},{"key":"10.1157\/13074395_bib57","doi-asserted-by":"crossref","first-page":"2197","DOI":"10.1097\/00005792-199705000-00006","article-title":"Chorea in the antiphospholipid syndrome: clinical, radiologic, and immunologic characteristics of 50 patients from our clinic and recent literature","volume":"76","author":"Cervera","year":"1997","journal-title":"Medicine (Baltimore)"},{"key":"10.1157\/13074395_bib58","doi-asserted-by":"crossref","first-page":"1142","DOI":"10.1136\/jnnp.57.9.1142","article-title":"Ischaemic optic neuropathy, transverse myelitis, and epilepsy in an anti-phospholipid positive patient with systemic lupus erythematosus","volume":"57","author":"Cordeiro","year":"1994","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"10.1157\/13074395_bib59","doi-asserted-by":"crossref","first-page":"324","DOI":"10.1177\/096120339500400417","article-title":"Benign intracranial hypertension: a non-thrombotic complication of the primary antiphospholipid syndrome?","volume":"4","author":"Orefice","year":"1995","journal-title":"Lupus"},{"key":"10.1157\/13074395_bib60","doi-asserted-by":"crossref","first-page":"817","DOI":"10.1001\/archneur.55.6.817","article-title":"Anticardiolipin antibodies are frequently present in patients with idiopathic intracranial hypertension","volume":"55","author":"Leker","year":"1998","journal-title":"Arch Neurol"},{"key":"10.1157\/13074395_bib61","doi-asserted-by":"crossref","first-page":"482","DOI":"10.1097\/00004583-200104000-00018","article-title":"Case series: neuropsychiatric symptoms with pediatric systemic lupus erythematosus","volume":"40","author":"Turkel","year":"2001","journal-title":"J Acad Child Adolesc Psychiatry"},{"key":"10.1157\/13074395_bib62","doi-asserted-by":"crossref","first-page":"20","DOI":"10.4088\/JCP.v59n0105","article-title":"High association of anticardiolipin antibodies with psychosis","volume":"59","author":"Schwatz","year":"1998","journal-title":"J Clin Psychiatry"},{"key":"10.1157\/13074395_bib63","first-page":"983","article-title":"Neuropsychiatric manifestations in systemic lupus erythematosus: prevalence and association with antiphospholipid antibodies","volume":"30","author":"Sanna","year":"2003","journal-title":"J Rheumatol"},{"key":"10.1157\/13074395_bib64","doi-asserted-by":"crossref","first-page":"220","DOI":"10.1016\/0196-0709(95)90109-4","article-title":"Sudden sensorioneural hearing loss and anticardiolipin antibody","volume":"16","author":"Tumiati","year":"1995","journal-title":"Am J Otolaryngol"},{"key":"10.1157\/13074395_bib65","doi-asserted-by":"crossref","first-page":"540","DOI":"10.1177\/096120339700600611","article-title":"Autoimmune aberration in sudden sensorineural hearing loss: association with anticardiolipin antibodies","volume":"6","author":"Toubi","year":"1997","journal-title":"Lupus"},{"key":"10.1157\/13074395_bib66","first-page":"589","article-title":"Sudden sensorineural hearing loss in patients with systemic lupus erythematosus or lupus-like syndromes and antiphospholipid antibodies","volume":"25","author":"Naarendorp","year":"1998","journal-title":"J Rheumatol"},{"key":"10.1157\/13074395_bib67","doi-asserted-by":"crossref","first-page":"1361","DOI":"10.1016\/S0140-6736(83)91113-3","article-title":"Antiphospholipid antibodies in acute Guillain-Barr\u00e9 syndrome","volume":"2","author":"Harris","year":"1983","journal-title":"Lancet"}],"container-title":["Medicina Cl\u00ednica"],"original-title":[],"language":"es","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0025775305718376?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0025775305718376?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2023,5,3]],"date-time":"2023-05-03T04:14:07Z","timestamp":1683087247000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0025775305718376"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2005,4]]},"references-count":67,"journal-issue":{"issue":"16","published-print":{"date-parts":[[2005,4]]}},"alternative-id":["S0025775305718376"],"URL":"https:\/\/doi.org\/10.1157\/13074395","relation":{},"ISSN":["0025-7753"],"issn-type":[{"value":"0025-7753","type":"print"}],"subject":[],"published":{"date-parts":[[2005,4]]}}}